Kolling Institute News

Anh Pham from the Bowel Cancer and Biomarker Lab: travelling to Singapore and Malaysia Anh will travel to the

He said he is honoured to receive the award which came as a wonderful surprise. “It is a great opportunity to build international collaborations and develop advanced imaging approaches that support the translation of regenerative therapies into clinical practice,” he said. Helen Patterson from the John Walsh Centre for Rehabilitation Research: travelling to London and Kuala Lumpur

Human Proteome Organisation World

Congress in Singapore and the Metaproteomic Symposium in Malaysia, two of the leading international bowel cancer research conferences. The trips will support Anh’s

The award will allow Helen to attend two international conferences where she will present a workshop on rehabilitation after nerve transfer in tetraplegia at

research investigating an anti-diabetic agent, as a chemo-preventive therapy for colorectal cancer. Anh said the trips will be a great opportunity to present her work to a global audience, connect with world-leading researchers, and bring back cutting- edge insights. “Receiving this travel award is such an honour and I am incredibly grateful for the support,” she said. “Travelling to Singapore and Malaysia will be a career highlight, which will help me gain expert knowledge from proteomic world leaders and further my research here at Kolling. I am excited to represent Kolling Institute and our research.” Dingyuan Fan from the Osteoarthritis Clinical Research Group: travelling to Spain and Austria Dingyuan will present his research poster at the World Congress on

the World TetraHand Congress in London, and present at the International Spinal Cord Society’s 2026 Annual Scientific Meeting in Kuala Lumpur.

The meetings will help Helen share the results of her work and learn more about the research and treatment advances for people with spinal cord injury. This will help extend Helen’s studies on a more robust protocol for rehabilitation after nerve transfer surgery. “I felt lucky to have the opportunity to apply for a travel scholarship through the Kolling Institute, so was delighted when I found out that I was to be a recipient. “To be supported to travel overseas is a privilege and I am incredible grateful,” she said. These opportunities would not be possible without the financial boost delivered through the Skipper Charitable Trust. Academic Director Professor James Elliott would like to thank the Skipper family for their wonderful ongoing support of our early and mid-career investigators, and the NORTH Foundation for their continued support. “Their help is directly broadening the Kolling’s research expertise and impact,” he said.

Osteoarthritis in Spain in 2027. Dingyuan’s research uses biomarkers to investigate structural cartilage changes

following regenerative therapy, with a focus on improving the assessment of treatment response in osteoarthritis.

Following the conference, Dingyuan will visit Professor Felix Eckstein at Paracelsus Medical University in Austria. The trip will help build international collaborations and develop advanced imaging approaches to support the translation of regenerative therapies into clinical practice.

11

WWW.KOLLINGINSTITUTE.ORG.AU

Made with FlippingBook - professional solution for displaying marketing and sales documents online